Zollinger-Ellison syndrome happens when tumors called gastrinomas cause too much stomach acid. Here's all you need to know ...

HER2-negative breast cancer. The drug, called Datroway (datopotamab deruxtecan), is approved for patients who have already ...

Multiple endocrine neoplasia type 1 (MEN1) is a hereditary tumor syndrome characterized by tumors of the parathyroid glands, the pancreatic islets, the pituitary gland, the adrenal glands ...

Donald Patrick McDonnell, Ph.D., has been awarded the Endocrine Society’s John D. Baxter Prize for Entrepreneurship for discovering hormone therapies for treating breast and prostate cancer, the ...

Researchers found that moderate triclosan exposure is significantly linked to increased breast cancer risk, particularly in ...

Among patients with advanced PIK3CA-mutated, HR-positive/HER2-negative breast cancer, Itovebi-based treatment generated ...

Paolo Tarantino, MD, PhD, discusses the approval of the oral therapy elacestrant for patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer with ESR1 mutations.

Compared with endocrine therapy, radiotherapy was associated with a smaller reduction in health-related quality-of-life in ...